alendronate has been researched along with Hemolysis in 5 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the use of Alen has been limited due to its low bioavailability and gastrointestinal side effects." | 5.62 | Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment. ( Chen, S; Jing, C; Li, B; Liang, H; Liu, C; Na, H; Tan, H; Zhang, C; Zhao, L, 2021) |
| " However, the use of Alen has been limited due to its low bioavailability and gastrointestinal side effects." | 1.62 | Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment. ( Chen, S; Jing, C; Li, B; Liang, H; Liu, C; Na, H; Tan, H; Zhang, C; Zhao, L, 2021) |
| "Alendronate sodium is a medicine, which is commonly used in osteoporosis treatment." | 1.37 | The effect of alendronate sodium on human erythrocytes. ( Bukowska, B; Duda, W; Janiszewska, S; Kopka, A; Szwed, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, C | 1 |
| Li, B | 1 |
| Tan, H | 1 |
| Zhang, C | 1 |
| Liang, H | 1 |
| Na, H | 1 |
| Chen, S | 1 |
| Liu, C | 1 |
| Zhao, L | 1 |
| Zhu, J | 1 |
| Huo, Q | 1 |
| Xu, M | 1 |
| Yang, F | 1 |
| Li, Y | 1 |
| Shi, H | 1 |
| Niu, Y | 1 |
| Liu, Y | 1 |
| Clementi, C | 1 |
| Miller, K | 1 |
| Mero, A | 1 |
| Satchi-Fainaro, R | 1 |
| Pasut, G | 1 |
| Kopka, A | 1 |
| Janiszewska, S | 1 |
| Szwed, M | 1 |
| Duda, W | 1 |
| Bukowska, B | 1 |
| Cenni, E | 1 |
| Granchi, D | 1 |
| Avnet, S | 1 |
| Fotia, C | 1 |
| Salerno, M | 1 |
| Micieli, D | 1 |
| Sarpietro, MG | 1 |
| Pignatello, R | 1 |
| Castelli, F | 1 |
| Baldini, N | 1 |
5 other studies available for alendronate and Hemolysis
| Article | Year |
|---|---|
Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment.
Topics: Alendronate; Alginates; Animals; beta-Cyclodextrins; Bone and Bones; Bone Density Conservation Agent | 2021 |
Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Bortezomib; Breast Neoplasms; Catechols | 2018 |
Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Topics: Alendronate; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dendrimer | 2011 |
The effect of alendronate sodium on human erythrocytes.
Topics: Acetylcholinesterase; Alendronate; Bone Density Conservation Agents; Diphosphonates; Erythrocytes; G | 2011 |
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
Topics: Alendronate; Alkaline Phosphatase; Cell Survival; Hemolysis; Humans; Lactic Acid; Leukocyte Count; M | 2008 |